The combination of ARB and CCB in type 2 diabetic hypertensive patients

The combination of ARB and CCB in type 2 diabetic hypertensive patients - The combination of ARB and CCB in type 2 diabetic hypertensive patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008119

Enrollment

300

Registered

2012-06-11

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension with type 2 diabetis

Interventions

Olmesartan and Azelnidipine Telmisartan and Amlodipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertension in the presence of type 2 diabetes mellitus Systolic pressure or diastolic pressure at medical examination exceeding 130 mmHg or 80 mmHg

Exclusion criteria

Exclusion criteria: Diabetic nephropathy after the late stage of overt nephropathy History of acute coronary syndrome or cerebrovascular disorders within one year of enrolment Severe infection before or after surgery or serious trauma History of hypersensitivity to the study drugs Pregnant women or women with the possibility of being pregnant

Design outcomes

Primary

Measure	Time frame
Early-morning blood pressure Heart rate Renal function Glucose/lipid metabolism	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026